Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2269976
Max Phase: Preclinical
Molecular Formula: C23H33N3O4
Molecular Weight: 415.53
Molecule Type: Small molecule
Associated Items:
ID: ALA2269976
Max Phase: Preclinical
Molecular Formula: C23H33N3O4
Molecular Weight: 415.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCc1cc(C(=O)N(CCOc2ccc(CCOCC)cc2C)C(C)=O)n(C)n1
Standard InChI: InChI=1S/C23H33N3O4/c1-6-8-20-16-21(25(5)24-20)23(28)26(18(4)27)12-14-30-22-10-9-19(15-17(22)3)11-13-29-7-2/h9-10,15-16H,6-8,11-14H2,1-5H3
Standard InChI Key: MQHQGRDBCOZUSU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.53 | Molecular Weight (Monoisotopic): 415.2471 | AlogP: 3.33 | #Rotatable Bonds: 11 |
Polar Surface Area: 73.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.92 | CX LogP: 3.34 | CX LogD: 3.34 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.53 | Np Likeness Score: -1.04 |
1. OBATA T, FUJII K, FUNAKI E, TSUTSUMIUTI K, OHOKA A, SUIZU S, KANETSUKI Y. (1999) Synthesis and Selective Bioactivity of New Pyrazolecarboxamide Derivatives, 24 (1): [10.1584/jpestics.24.33] |
Source(1):